Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2005 2
2006 5
2007 4
2008 3
2009 6
2010 5
2011 4
2012 7
2013 6
2014 17
2015 10
2016 12
2017 3
2018 2
2019 6
2020 5
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J. Garg M, et al. Among authors: royce sg. Gut. 2020 May;69(5):841-851. doi: 10.1136/gutjnl-2019-318512. Epub 2019 Aug 13. Gut. 2020. PMID: 31409604
Anti-fibrotic actions of relaxin.
Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG. Samuel CS, et al. Among authors: royce sg. Br J Pharmacol. 2017 May;174(10):962-976. doi: 10.1111/bph.13529. Epub 2016 Jul 7. Br J Pharmacol. 2017. PMID: 27250825 Free PMC article. Review.
Risk factors for eosinophilic esophagitis.
Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR. Philpott H, et al. Among authors: royce sg. Clin Exp Allergy. 2014 Aug;44(8):1012-9. doi: 10.1111/cea.12363. Clin Exp Allergy. 2014. PMID: 24990069 Review.
Eosinophilic esophagitis: a clinicopathological review.
Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. Philpott H, et al. Among authors: royce sg. Pharmacol Ther. 2015 Feb;146:12-22. doi: 10.1016/j.pharmthera.2014.09.001. Epub 2014 Sep 6. Pharmacol Ther. 2015. PMID: 25200122 Review.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page